Ascension Via Christi Cancer Center | Ascension
Ascension Via Christi Cancer Center

Ascension Via Christi Cancer Center

  • Cancer care


Call for daily hours


About Us

Specialists at Ascension Via Christi Cancer Center in Wichita, KS, deliver compassionate cancer care that's right for you.

Ascension Via Christi Cancer Center in Wichita, on the campus of Ascension Via Christi St. Francis, is a freestanding cancer treatment facility for outpatient cancer rehabilitation and radiation therapy, including our CyberKnife radiosurgery system.

Therapies offered at the Cancer Center are:

  • Intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT): External beam therapies, these allow for precise treatment of deadly tumors with less damage to health tissue.
  • High-dose-rate brachytherapy: This precise treatment places a source of radiation in close proximity to the tumor, allowing the delivery of high doses of radiation while sparing healthy tissue.

CyberKnife targeted radiation therapy, available at Ascension Via Christi’s Cancer Center in Wichita, is a noninvasive alternative to surgery for treating tumors anywhere in the body, even hard-to-reach tumors that can’t be removed surgically. By delivering high-dose radiation with accuracy, this offers many patients new options that were not possible in the past. CyberKnife is most often used to treat breast, bone, prostate and lung cancer.

CyberKnife offers patients treatment with:

  • No incision
  • No anesthesia
  • No pain
  • No need for an immobilizing head frame during treatment
  • Minimal recovery time
  • Rapid return to normal activity

For more information about CyberKnife treatment at Ascension Via Christi, talk with your doctor or call the Ascension Via Christi CyberKnife Center at 316-261-3200 or 800-362-0070 ext. 3200.

Ascension Via Christi Cancer Center is now an approved site for the treatment of advanced metastatic prostate cancer with Pluvicto®, an FDA-approved therapy that studies have shown improves prostate cancer survival rates, slows the disease's progression and improves patients' quality of life.